Planning and evaluation is primarily overseen by the KCC Executive Committee (EC), which meets on a monthly basis and is responsible for the overall assessment of the quality and effectiveness of the basic, translational and clinical research programs. EC Members include the Director, Deputy Director, Basic and Clinical Sciences Directors, the Associate and Assistant Directors of Shared Resources, and the Director of Administration. The Center Director and senior leadership are also guided by the advise and recommendations of the Internal and External Advisory Committees The Internal Advisory Committee, which meets quarterly, is composed of all Jefferson Medical College Department Chairmen or their designees, the CEO of Thomas Jefferson University Hospital, and the Dean of Jefferson Medical College. Additional participants in this meeting are the KCC Executive Committee and Program Leaders. This committee is charged with the responsibility of advising Dr. Croce and the Executive Committee on the Center's progress and new opportunities. The External Scientific Advisory Committee (SAC) holds a two day meeting every year at the KCC. The SAC is currently chaired by Dr. Clara Bloomfield (Ohio State University), and also consists of Drs. Stuart Aaaronson (Mount Sinai College of Medicine), Martin Abeloff (Johns Hopkins University), Ronald Blum (New York University), Paul Bunn (University of Colorado), Donald Coffey (Johns Hopkins University), David Golde (Memorial Sloan-Kettering Cancer Center), Waun Ki Hong (MD Anderson Cancer Center), David Johnson (Vanderbilt University), Peter Nowell (University of Pennsylvania), Bert O'Malley (Baylor College of Medicine), Steven Rosen (Northwestern University), George Vande Woude (Van Ardel Research Institute), and Ralph Weichselbaum (University of Chicago).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA056036-04A2
Application #
6485632
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
1995-06-22
Project End
2006-05-31
Budget Start
Budget End
Support Year
4
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Type
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Liao, Lili; Liu, Zongzhi Z; Langbein, Lauren et al. (2018) Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer. Elife 7:
Heeke, Arielle L; Pishvaian, Michael J; Lynce, Filipa et al. (2018) Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types. JCO Precis Oncol 2018:
Parent, Kristin N; Schrad, Jason R; Cingolani, Gino (2018) Breaking Symmetry in Viral Icosahedral Capsids as Seen through the Lenses of X-ray Crystallography and Cryo-Electron Microscopy. Viruses 10:
Rappaport, Jeffrey A; Waldman, Scott A (2018) The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia. Front Oncol 8:299
Pandya, Kalgi D; Palomo-Caturla, Isabel; Walker, Justin A et al. (2018) An Unmutated IgM Response to the Vi Polysaccharide of Salmonella Typhi Contributes to Protective Immunity in a Murine Model of Typhoid. J Immunol 200:4078-4084
Hussain, Maha; Daignault-Newton, Stephanie; Twardowski, Przemyslaw W et al. (2018) Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012. J Clin Oncol 36:991-999
Shafi, Ayesha A; Schiewer, Matthew J; de Leeuw, Renée et al. (2018) Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response. Eur Urol Oncol 1:325-337
Meyer, Sara E; Muench, David E; Rogers, Andrew M et al. (2018) miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential. J Exp Med 215:2115-2136
Mazina, Olga M; Mazin, Alexander V (2018) Reconstituting the 4-Strand DNA Strand Exchange. Methods Enzymol 600:285-305
Magee, Michael S; Abraham, Tara S; Baybutt, Trevor R et al. (2018) Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases. Cancer Immunol Res 6:509-516

Showing the most recent 10 out of 807 publications